RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+4.03%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.54B
AUM Growth
+$6.54B
(-1.1%)
Cap. Flow
+$38.9M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
52.67%
Holding
82
New
10
Increased
17
Reduced
8
Closed
14
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$100M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$65.3M |
| 3 |
GE HealthCare
GEHC
|
$42M |
| 4 |
BBNX
Beta Bionics, Inc. Common Stock
BBNX
|
$40.4M |
| 5 |
uniQure
QURE
|
$35.6M |
Top Sells
| 1 |
Bruker
BRKR
|
$145M |
| 2 |
Axsome Therapeutics
AXSM
|
$132M |
| 3 |
89bio
ETNB
|
$40.1M |
| 4 |
Dyne Therapeutics
DYN
|
$36.9M |
| 5 |
Alkermes
ALKS
|
$22.2M |
Sector Composition
| 1 | Healthcare | 99.88% |
| 2 | Financials | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
PepGen
PEPG
$39.4M
| – | – |
-3,193,097
| Closed | -$12.1M |
|
77
Regenxbio
RGNX
$489M
| – | – |
-350,000
| Closed | -$2.71M |
|
78
Roivant Sciences
ROIV
$8.56B
| – | – |
-1,454,273
| Closed | -$17.2M |
|
|
SAGE
79
DELISTED
Sage Therapeutics
SAGE
| – | – |
-3,002,370
| Closed | -$16.3M |
|
|
SLRN
80
DELISTED
ACELYRIN
SLRN
| – | – |
-978,310
| Closed | -$3.07M |
|
81
Tourmaline Bio
TRML
$634M
| – | – |
-736,681
| Closed | -$14.9M |
|
|
ARTV
82
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$74.6M
| – | – |
-148,844
| Closed | -$1.5M |
|